SHANGHAI -- Taibang Biologic Group has raised $300 million from investors including the Abu Dhabi Investment Authority and Singaporean sovereign wealth fund GIC, the Chinese company said Tuesday.
Pharmaceuticals
Chinese biopharma Taibang raises $300m, stirs relisting murmurs
Investment in former China Biologic led by Singapore, Abu Dhabi funds
Singaporean sovereign wealth fund GIC co-led the $300 million fundraising round for Taibang Biologic. © Reuters
Read Next
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Pharmaceuticals
